Category Cardiovascular

Other Adjunctive Drugs for Coronary Intervention: Beta-Blockers, Calcium-Channel Blockers, and Angiotensin-Converting Enzyme Inhibitors

Key Points β-Blockers provide long-term mortality reduction after myocardial infarction (MI). Although β-blockers are beneficial, they should be used carefully immediately after MI to avoid cardiogenic shock in susceptible patients. Calcium-channel blockers are reasonable alternatives to β-blockers after MI in…

Thrombolytic Intervention

Key Points Thrombolytic therapy remains the preferred reperfusion strategy in patients with ST-elevation myocardial infarction (STEMI) who present within 12 hours of symptom onset when timely primary percutaneous coronary intervention (PCI) is not available and no contraindications to thrombolysis are…

Platelet Inhibitor Agents

Key Points Dual-antiplatelet therapy (DAPT) with aspirin and a P2Y 12 receptor inhibitor is the cornerstone of therapy after percutaneous coronary intervention (PCI) with stents. The thienopyridines—ticlopidine, clopidogrel, and prasugrel—are P2Y 12 inhibitors that are prodrugs and therefore require conversion…